상세 보기
자료 필터
자료유형
발행연도
2025 ~ 2025
2025 2025
키워드
언어
전체 7건 중 1번부터 7번까지의 결과를 표시합니다.
2025
Article
Topical Nanocarrier-Assisted Corticosteroid Delivery Combined with Phototherapy for Effective Atopic Dermatitis Treatment
- Choi, Young-Ae ;
- Park, Jun Young ;
- Kang, Jinjoo ;
- Jeong, Na-Hee ;
- Lee, Soyoung ;
- ... Kim, Sang-Hyun ;
- 외 1명
- 2025-10
- ACS Applied Bio Materials
- AMER CHEMICAL SOC
Article
Amygdalin alleviates atopic dermatitis-like skin inflammation via inhibition of Th2 immune responses
- Won, Seonbin ;
- Jeong, Na-Hee ;
- Choi, Young-Ae ;
- Jin, Meiling ;
- Park, Hyo-Hyun ;
- ... Lee, Soyoung ;
- ... Kim, Sang-Hyun
- 2025-09-03
- Immunopharmacology and Immunotoxicology
- TAYLOR & FRANCIS LTD
Article
Amygdalin alleviates atopic dermatitis-like skin inflammation via inhibition of Th2 immune responses
- Seonbin, W. ;
- Na-Hee, J. ;
- Young-Ae, C. ;
- Soyoung, L. ;
- Sang-Hyun, K.
- 2025-07
- FEBS Open Bio
- WILEY
Article
Protectin D1, an omega-3–derived lipid mediator, resolves mast cell–driven allergic inflammation via FcεRⅠ signaling
- Yoon, Jieun ;
- Kim, Daheen ;
- Jeong, Nahee ;
- Choi, Young-ae ;
- Kwon, Taeg-kyu ;
- ... Lee, Soyoung ;
- ... Kim, Sang-hyun ;
- 외 1명
- 2025-06
- Biomedicine & Pharmacotherapy
- Elsevier Masson s.r.l.
Article
Toxicity Assessment of Doxorubicin and Doxil in Single Intravenously Exposed Mice for the Development of New Anticancer Nanodrugs
- Jeong, Seungwon ;
- Lee, Soyoung
- 2025-03
- Journal of Pharmacology and Experimental Therapeutics
- ELSEVIER
Article
Esculetin Inhibits Mast Cell-Mediated Allergic Inflammation and Anaphylaxis by Suppressing the FcRI Signaling Pathway
- Kim, Daheen ;
- Jeong, Seungwon ;
- Lee, Soyoung ;
- Kim, Sang-Hyun
- 2025-03
- Journal of Pharmacology and Experimental Therapeutics
- ELSEVIER
Article
Aspalathin, a key flavonoid in rooibos, restores STAT6-mediated immune dysregulation in atopic dermatitis
- Yang, Inyoung ;
- Jeong, Nahee ;
- Choi, Young-ae ;
- Choi, Dong-kyu ;
- Lee, Hyun‑Shik ;
- ... Lee, Soyoung ;
- ... Kim, Sang-hyun ;
- 외 1명
- 2025-03
- Biomedicine & Pharmacotherapy
- Elsevier Masson s.r.l.